Clene(CLNN) - 2025 Q2 - Quarterly Results

In April, Clene presented new evidence of remyelination and neuronal repair with CNM-Au8 treatment at the American Academy of Neurology (AAN) Late-Breaking Science Session at the AAN 2025 Annual Meeting. The presentation, titled "Physiologic and Anatomical Evidence of Neuronal Repair and Remyelination from the Long-Term Open-Label Extension of the Phase 2 VISIONARY-MS Trial," highlighted significant and clinically meaningful improvements in cognition and visual function, supported by corresponding objective ...